Publication | Open Access
Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non–Small Cell Lung Cancer With High Tumor Mutation Burden
42
Citations
32
References
2022
Year
ClinicalTrials.gov Identifier: NCT03836066.
| Year | Citations | |
|---|---|---|
Page 1
Page 1